MARIO CELAYA: Open Payments
NPI 1124173786 · LINDSAY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,033 in 64 payments from 13 companies in 2025. Trend: 2023 $1,931 · 2024 $2,506 · 2025 $1,033
Food & beverage: $948Education: $85
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $250 |
| Novo Nordisk Inc | 7 | $172 |
| Amgen Inc. | 21 | $164 |
| Phathom Pharmaceuticals, Inc. | 8 | $108 |
| Mannkind Corporation | 2 | $85 |
| Antares Pharma, Inc. | 3 | $54 |
| ANI Pharmaceuticals, Inc. | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Dexcom, Inc. | 1 | $17 |
Products named: ZEPBOUND, Wegovy, VOQUEZNA, TEZSPIRE, AFREZZA, OTEZLA, XYOSTED, PURIFIED CORTROPHIN GEL.
Industry payments across CA — which companies pay providers there.
